XML 42 R18.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Schedule of Disaggregated Revenue

For the year ended December 31, 2020 and 2019, the Company had the following disaggregated revenue:

 

    Year Ended December 31,  
    2020     %     2019     %  
Product revenues by Brand for CVLB PR:                                
Shapiro MD   $ 17,289,687       46     $ 9,019,956       72  
Innate     5,041       -       49,258       -  
iNR Wellness     247,350       1       738,965       6  
Scarology     44,332       -       51,131       -  
Rex MD     12,969,753       35       60,197       -  
Total product revenue for CVLB PR   $ 30,556,163       82     $ 9,919,507       80  
                                 
Software revenue for LegalSimpli, net     6,732,747       18       2,539,129       20  
                                 
Services revenue for CVLB Media     5,000       -       9,943       -  
                                 
Total Revenues, net   $ 37,293,910       100     $ 12,468,578       100  
Summary of Inventory

As of December 31, 2020 and 2019, the Company’s inventory consisted of the following:

 

    December 31,     December 31,  
    2020     2019  
             
Finished Goods - Products   $ 1,172,624       925,017  
Raw materials and packaging components     149,115       37,542  
Inventory reserve     (57,481 )     (12,500 )
Total Inventory - net   $ 1,264,258     $ 950,059  
Schedule of Potentially Dilutive Securities

The following table summarizes the number of shares of common stock issuable pursuant to our convertible securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive even though the exercise price could be less than the average market price of the common shares:

 

   

Year

Ended

   

Year

Ended

 
    December 31,     December 31,  
    2020     2019  
             
Series B Preferred Stock     1,076,923       -  
Convertible notes     -       2,165,126  
Stock options     4,232,400       4,374,000  
Warrants     3,560,188       2,265,324  
Potentially dilutive securities     8,869,511       8,804,451